SEC Form 4/A · accession 0001104659-15-063544
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Thomas J. Lowery
Officer — Chief Scientific Officer
Period of report
Aug 12, 2015
Accepted (ET)
Sep 3, 2015 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 12, 2015 | M | 2,000 | $2.45 | A | 6,411 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.45 | Aug 12, 2015 | M | 2,000 | D | — | Feb 5, 2020 | Common Stock | 2,000 | 36,235 | D |
Explanation of responses
- F1The original Form 4 filed on August 14, 2015 is amended by this Form 4 amendment to correct the designation for securities acquired or disposed of.
- F2The Stock Option vested as to 25% of the underlying shares on January 17, 2013 and the remaining shares vested or will vest in 36 equal monthly installments thereafter.